SalaryGuide
AboutPricingFor Employers

Marketing jobs

27 marketing jobs

Boston Scientific logo
3 months ago

Principal Digital Marketing Manager - 18-Month Defined Term

Boston Scientific

Arden Hills, MN (Hybrid)Full time$82K/yr – $156K/yr
Boston Scientific logo
3 months ago

Senior Product Manager, Global Downstream Marketing EUS

Boston Scientific

Massachusetts, USA (Hybrid)Full time$107K/yr – $203K/yr
Boston Scientific logo
3 months ago

Segment Marketing Lead, Surgical Endoscopy and National Accounts

Boston Scientific

Marlborough, MA (On-site)Full time$120K/yr – $150K/yr
Boston Scientific logo
4 months ago

Manager, Integrated Marketing Operations

Boston Scientific

Massachusetts, USA (Hybrid)Full time$107K/yr – $203K/yr
Boston Scientific logo
4 months ago

Senior Manager, Omnichannel Marketing (Patient)

Boston Scientific

Massachusetts, USA (Hybrid)Full time$126K/yr – $239K/yr
Boston Scientific logo
4 months ago

Senior Manager, Global Brand Marketing

Boston Scientific

Arden Hills, MN (Hybrid)Full time$132K/yr – $250K/yr
Boston Scientific logo
4 months ago

Market Development Manager (MDM), Bariatric Surgeon

Boston Scientific

Massachusetts, USA (Unknown)Full time$120K/yr – $150K/yr
Previous
12
Next

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

27 jobs
Boston Scientific logo

Principal Digital Marketing Manager - 18-Month Defined Term

Boston Scientific

Arden Hills, MN (Hybrid)

$82K/yr - $156K/yrIn-houseFull-timeSenior level4+ years exp.
3 months ago
Boston Scientific logo

Senior Product Manager, Global Downstream Marketing EUS

Boston Scientific

Massachusetts, USA (Hybrid)

$107K/yr - $203K/yrIn-houseFull-timeSenior level5+ years exp.
3 months ago
Boston Scientific logo

Segment Marketing Lead, Surgical Endoscopy and National Accounts

Boston Scientific

Marlborough, MA (On-site)

$120K/yr - $150K/yrIn-houseFull-timeSenior level10+ years exp.
3 months ago
Boston Scientific logo

Manager, Integrated Marketing Operations

Boston Scientific

Massachusetts, USA (Hybrid)

$107K/yr - $203K/yrIn-houseFull-timeMid level8+ years exp.
4 months ago
Boston Scientific logo

Senior Manager, Omnichannel Marketing (Patient)

Boston Scientific

Massachusetts, USA (Hybrid)

$126K/yr - $239K/yrIn-houseFull-timeSenior level8+ years exp.
4 months ago
Boston Scientific logo

Senior Manager, Global Brand Marketing

Boston Scientific

Arden Hills, MN (Hybrid)

$132K/yr - $250K/yrIn-houseFull-timeSenior level8+ years exp.
4 months ago
Boston Scientific logo

Market Development Manager (MDM), Bariatric Surgeon

Boston Scientific

Massachusetts, USA (Unknown)

$120K/yr - $150K/yrIn-houseFull-timeSenior level8+ years exp.
4 months ago
Previous12
Boston Scientific logo
Boston Scientific

Principal Digital Marketing Manager - 18-Month Defined Term

Arden Hills, MN (Hybrid)

$82K/yr – $156K/yrSenior Level4+ years expFull time

Posted 3 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive integrated digital strategy and activation across CRM, web, and campaigns to support cross-functional marketing goals.

  • Own planning, execution, and measurement of digital campaigns targeting key audiences.
  • Must-have: 4+ years in marketing/digital within a B2C or B2B environment with proven campaign results.
  • Proven ability to partner with analytics teams and deliver actionable performance reports.

Job Description

Responsibilities

  • Support the development of the overall digital strategy, including CRM (email, text), web, SEO/SEM, and other key digital channels, in alignment with the broader marketing to ensure an integrated marketing campaign strategy and activation.
  • Lead projects encompassing the planning, execution, and measurement of digital campaigns targeting key audiences.
  • Contribute to journey mapping exercises with cross-functional teams, developing tactical integrated communication plans that align with the customer journey.
  • Partner with analytics resources to demonstrate the value of campaigns and provide a consistent cadence of performance reports.
  • Regularly monitor analytics for campaigns and digital channels, collaborating with corporate analytics teams to create measurement plans and deliver insightful campaign reports to key stakeholders and leadership.
  • Manage multiple programs simultaneously, effectively prioritizing work to contribute to the digital strategy while owning activation, execution, and implementation.
  • Influence various functions and levels within the organization through strong interpersonal communication, written, and presentation skills.
  • Proactively communicate and present fresh, innovative, and relevant ideas and plans to business partners, securing alignment and buy-in.

Requirements

  • Bachelors degree in a relevant field, with a strong preference for marketing.
  • Minimum of 4 years of experience in marketing, communications, and/or digital marketing within a B2C or B2B environment.
  • Demonstrated expertise in digital marketing, with a proven track record of developing and executing successful digital campaigns and programs.
  • Proficiency in Google Analytics and familiarity with data visualization tools such as Tableau.
  • Comprehensive understanding of inbound and outbound email marketing, organic and paid search engine marketing, social media marketing, content marketing, website strategy, customer relationship management, webcasts/webinars, and related digital marketing strategies.
  • Ability to work effectively as part of a regionally diverse team in a fast-paced environment.
  • Willingness to travel up to 10% based on business needs.
  • Availability for travel and overtime as required by business commitments.

Preferred

  • MBA or advanced degree in a related field.
  • Experience with Salesforce and Salesforce Marketing tools, including Marketing Cloud, as well as Adobe Experience Manager.
Boston Scientific logo

Boston Scientific

4.1 Glassdoor

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions.For more information, visit www.bostonscientific.com and connect with us on X, Instagram, and Facebook. At Boston Scientific, you will find purpose, a place to grow and opportunities to cultivate your passions. To search and apply for open positions, visit https://bostonscientific.eightfold.ai/careers. You may also review our social media guidelines at http://www.bostonscientific.com/social.

Founded in 2008
Marlborough, Massachusetts, USA
52K employees (2,281 in marketing)
www.bostonscientific.com
84% recommend to a friend
92% CEO approval

Traffic Signals

Monthly Visitors
560.3K
Monthly Google Ads Budget
$51.3K
Traffic Source Mix
Search
60%
Direct
31.3%
Referral
6.1%
Social
1.5%
Paid
1.1%

Headcount Trend

Current headcount: ~51.8K

Marketing Team

Marketing Team Size
1,778 (3% of company)
Median Career Experience
18 years
Median Tenure
8.6 years
Marketing Roles Posted (Last 30 Days)
14

People

Marketing Leadership

Mary Beth Moynihan
Mary Beth Moynihan
SVP, Market Access and Chief Marketing Officer
At the company for 29 years 7 months
Debra Sanchez
Debra Sanchez
Vice President Global Marketing
At the company for 26 years 7 months
Brooke Allocco
Brooke Allocco
Vice President, Cardiology Marketing and Digital Enablement
At the company for 21 years 6 months
Sara Koenck
Sara Koenck
Vice President Marketing, Peripheral Vascular
At the company for 16 years 3 months

Funding

Total Funding
$10B
Last Raise
$1.6B
Post IPO Debt, 1 years ago

Funding History

  • Feb 2025
    Post IPO Debt • $1.6B
  • Feb 2024
    Post IPO Debt • $2.2B
  • Mar 2022
    Post IPO Debt • $3.3B

Recent News

Boston Scientific pays high price for new Maple Grove facility
Dec 5, 2025 • Finance & Commerce
Boston Scientific claims European approval for Farapoint focal pulsed field ablation catheter
Dec 2, 2025 • Fierce Biotech
Boston Scientific partners with Epic on data integration
Nov 21, 2025 • Cardiovascular Business
Boston Scientific (BSX) Down 5.7% Since Last Earnings Report: Can It Rebound?
Nov 21, 2025 • Yahoo Finance
Boston Scientific, Epic collaborate on cardiac diagnostic EHR services
Nov 19, 2025 • MassDevice
Boston Scientific, Siemens Healthineers partner on cardiac catheter
Nov 17, 2025 • MedTech Dive
What Boston Scientific (BSX)'s Surging Sales and Siemens Partnership Mean for Shareholders
Nov 15, 2025 • Yahoo Finance
Siemens Healthineers and Boston Scientific partner on next-generation intracardiac echo for LAAO
Nov 14, 2025 • Cardiovascular Business
Boston Scientific Up 7% in a Month: How Should You Play the Stock?
Nov 14, 2025 • Yahoo Finance
Boston Scientific has a new tool to help TheraSphere fight cancer
Nov 12, 2025 • Medical Design & Outsourcing
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet
Nov 11, 2025 • Yahoo Finance
Boston Scientific (BSX): Evaluating Valuation After Strong Q3 Results and New Product Launches
Nov 6, 2025 • Yahoo Finance
Boston Scientific announces upcoming investor conference schedule
Nov 3, 2025 • PR Newswire
Boston Scientific announces upcoming investor conference schedule
Nov 3, 2025 • Yahoo Finance
Buy Boston Scientific Stock. It’s a Way to Diversify From AI?
Oct 30, 2025 • Barron's
Is Boston Scientific’s Rally Justified After Another Year of Double Digit Gains?
Oct 28, 2025 • Yahoo Finance
Boston Scientific shares positive Agent drug-coated balloon findings
Oct 27, 2025 • MassDevice
Should Boston Scientific’s (BSX) Upbeat Q3 Results and Raised Guidance Prompt Investor Action?
Oct 24, 2025 • Yahoo Finance
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?
Oct 23, 2025 • Yahoo Finance
Boston Scientific announces agreement to acquire Nalu Medical
Oct 23, 2025 • NeuroNews International
Boston Scientific continues to win in electrophysiology
Oct 22, 2025 • MedTech Dive
Earnings call transcript: Boston Scientific Q3 2025 beats forecasts, stock climbs
Oct 22, 2025 • Investing.com
Boston Scientific Beats on Q3 Earnings, Raises 2025 View, Stock Up
Oct 22, 2025 • Zacks Investment Research
Acquisitive Boston Scientific sees growth rate ease in Q3
Oct 22, 2025 • Fierce Biotech
Boston Scientific lifts annual profit forecast on strong demand for heart devices
Oct 22, 2025 • Yahoo Finance
Boston Scientific Makes A Bullish Move After Sales In One Segment Skyrocket 63%
Oct 22, 2025 • Investor's Business Daily
Boston Scientific announces results for third quarter 2025
Oct 22, 2025 • PR Newswire
Boston Scientific lifts annual profit forecast on strong demand for heart devices
Oct 22, 2025 • Reuters
Boston Scientific Raises Outlook on Continued Cardiovascular Growth - WSJ
Oct 22, 2025 • The Wall Street Journal
New Boston Scientific Facility Opens in Maple Grove
Oct 21, 2025 • Twin Cities Business
Analyst Visit Confirms Growth Potential for Boston Scientific Corporation (BSX), Buy Rating Retained
Oct 21, 2025 • Yahoo Finance
Boston Scientific to drop $533M to acquire neurostimulator maker Nalu Medical
Oct 20, 2025 • Fierce Biotech
New Boston Scientific facility opens in Maple Grove
Oct 20, 2025 • kare11.com
Boston Scientific Celebrates Opening of $170M Maple Grove Campus
Oct 20, 2025 • CCX Media -
Boston Scientific opens 400,000-square-foot facility in Maple Grove
Oct 20, 2025 • CBS News
Boston Scientific (BSX) Reports Q3: Everything You Need To Know Ahead Of Earnings
Oct 20, 2025 • Yahoo Finance
Latham & Watkins Advises Nalu Medical, Inc. on Acquisition by Boston Scientific
Oct 20, 2025 • Latham & Watkins LLP
Boston Scientific (BSX): Assessing Valuation as Shares Post Steady Gains
Oct 17, 2025 • Yahoo Finance
Boston Scientific Announces Intent to Acquire Nalu Medical
Oct 17, 2025 • Newsweek
Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.
Oct 17, 2025 • PR Newswire
Boston Scientific to acquire Nalu Medical for $533M
Oct 17, 2025 • MassDevice
Boston Scientific boosts chronic pain therapy portfolio with Nalu deal
Oct 17, 2025 • Reuters
Boston Scientific to buy Nalu Medical for $533M
Oct 17, 2025 • MedTech Dive
Boston Scientific to purchase California medtech for $533M
Oct 17, 2025 • Worcester Business Journal
Boston Scientific Dives Into Chronic Pain Through New Acquisition
Oct 17, 2025 • Medical Device and Diagnostic industry
Boston Scientific acquires Nalu Medical for $533m
Oct 17, 2025 • Medical Device Network
Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth
Oct 15, 2025 • Yahoo Finance
Is Boston Scientific’s Share Price Justified After Its Recent 7.6% Monthly Drop in 2025?
Oct 14, 2025 • Yahoo Finance
Boston Scientific (BSX) Stock Moves -1.92%: What You Should Know
Oct 10, 2025 • Yahoo Finance
Boston Scientific: Not In The Most Resolute State As It Approaches Q3 Earnings
Oct 9, 2025 • Seeking Alpha
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term
Oct 6, 2025 • Yahoo Finance
Inside Boston Scientific’s Acquisition Strategy
Oct 3, 2025 • Medical Device and Diagnostic industry
Boston Scientific aims for market leadership in electrophysiology
Oct 2, 2025 • MedTech Dive
Elutia closes $88M bioenvelope sale to Boston Scientific
Oct 1, 2025 • Drug Delivery Business
Boston Scientific unveils plans for new Watchman device
Oct 1, 2025 • MedTech Dive
Interventional Cardiology Devices Market to Reach US$39,234.52 million by 2033, at CAGR of 9.0% | Business Market Insights
Sep 29, 2025 • PR Newswire
3 Healthcare Stocks Using AI to Drive Growth
Sep 27, 2025 • MarketBeat
Renal Stents Market Growth Trends: US$2.08 Billion by 2033, Driven by CKD & Technological Advances | DataM Intelligence
Sep 26, 2025 • EIN Presswire
Why this $8-billion money manager likes Boston Scientific and Oracle
Sep 26, 2025 • Globe and Mail
More tariffs could hit Minnesota medtech companies
Sep 25, 2025 • Star Tribune
Neurostim Pain Devices Market to Reach USD 25,477.3 Million by 2035, Driven by Innovation in Chronic Pain Therapy
Sep 25, 2025 • EIN Presswire
Transjugular Intrahepatic Portosystemic Shunt Market to Hit $127.9 Mn, Globally, by 2031 at 3.2% CAGR
Sep 25, 2025 • EIN Presswire
Single-use Duodenoscope Market Forecasts and Competitive Strategies Report 2025-2033: Ambu and Boston Scientific Lead with Innovation and Infection-Free Solutions
Sep 24, 2025 • Research and Markets
SoCalBio Investor & Partnership Conference to Feature Keynotes from SetPoint CEO Murthy Simhambhatla, PhD, and MedTech Industry Deal-Maker Ray Cohen
Sep 24, 2025 • SoCalBio
Johnson & Johnson, Boston Scientific to Headline MEDevice Boston 2025 Keynote Sessions
Sep 23, 2025 • Yahoo Finance
With 8.2% CAGR Chronic Total Occlusion Market Size Surges US$ 4.22 billion by 2031 Amid Rising Cardiovascular Disease Burden | The Insight Partners
Sep 23, 2025 • PR Newswire UK
Medtech Leader Erica Rogers Joins Ceribell Board of Directors
Sep 22, 2025 • Ceribell
Boston Scientific Corporation (BSX) Expands AI-Enhanced Heart Devices With FARAPULSE Approval
Sep 21, 2025 • Yahoo Finance
Head of Boston Scientific’s Endoscopy unit is departing
Sep 19, 2025 • MassDevice
Top 3 Health Care Stocks That May Explode In September
Sep 19, 2025 • Benzinga.com
Boston Scientific Currently Down Nine Consecutive Days, on Pace for Longest Losing Streak Since September 2005 — Data Talk
Sep 19, 2025 • Morningstar.com
Boston Scientific Corporation (BSX) Rated as a ‘Buy’ at Needham on IVL Market Opportunity
Sep 18, 2025 • Yahoo Finance
Global Gastrointestinal Devices Market to Achieve 7% CAGR Rise with Growing Aging Population 2030
Sep 18, 2025 • PharmiWeb
T.Rx Capital Launches $77.5M Fund I to Invest in Bold Sta...
Sep 18, 2025 • PharmiWeb
InspireMD Announces the Appointment of Dan Dearen to its Board of Directors
Sep 18, 2025 • BioSpace
Moderna co-founder Robert Langer's son launches new VC with $77.5M, backing from dad
Sep 18, 2025 • FierceBiotech
Drug Eluting Balloon Catheter Market to Reach USD 9.4 Billion by 2035, Growing at a 18.0% CAGR | Fact.MR Report
Sep 17, 2025 • EIN Presswire
InspireMD Announces the Appointment of Dan Dearen to its Board of Directors
Sep 17, 2025 • InspireMD Inc.
Connected Health Market is Projected To Reach US$421.5 Billion By 2031 With CAGR of 6.5% During 2025-2031 | The Insight Partners
Sep 16, 2025 • PR Newswire UK
Oppenheimer Touts Boston Scientific Corporation (BSX) as the Best Large-Cap MedTech
Sep 15, 2025 • Yahoo Finance
FDA updates serious recall alert for Boston Scientific implanted defibrillator leads
Sep 15, 2025 • Fierce Biotech
FDA updates on Boston Scientific defibrillation recall related to 16 deaths
Sep 15, 2025 • MassDevice
Neuromodulation Market worth US$10.68 billion by 2030 with 9.4% CAGR | MarketsandMarkets™
Sep 15, 2025 • PR Newswire UK
Single Incision Laparoscopic Surgery Industry Report: Competitive Landscape and Future Prospects
Sep 15, 2025 • EIN Presswire
Neuromodulation Market worth US$10.68 billion by 2030 with 9.4% CAGR | MarketsandMarkets™
Sep 15, 2025 • PR Newswire
Reliability Ireland conference to be held in Kilkenny later this month
Sep 14, 2025 • Irish Examiner
Update on Alert: Defibrillation Lead Issue from Boston Scientific
Sep 12, 2025 • fda.gov
Interventional Neurology Devices Market Poised for Transformative Growth with Rising Stroke & Aneurysm Treatments 2025
Sep 12, 2025 • EIN Presswire
Mid-Urethral Sling Manufacturers: PVDF and P4HB Safer Materials versus Polypropylene
Sep 12, 2025 • EIN Presswire
Reliability Ireland Conference to Unite Global Experts on the Future of Engineering
Sep 12, 2025 • Irish Tech News
Boston Scientific (BSX): Examining Valuation Following Leadership Change and FARAPULSE FDA Rollout
Sep 11, 2025 • Yahoo Finance
Boston Scientific issues follow-up notice on Accolade pacemaker software update
Sep 11, 2025 • MassDevice
Boston Scientific inks $88M Elutia deal to challenge Medtronic
Sep 10, 2025 • Yahoo Finance
Boston Scientific to purchase Elutia’s drug-eluting envelope business for $88M
Sep 10, 2025 • Cardiovascular Business
Global Endoscopy Device Market to Double by 2034 Driven by Technological Innovations
Sep 10, 2025 • EIN Presswire
Elutia sells drug-eluting bioenvelope tech to Boston Scientific for $88M
Sep 9, 2025 • Drug Delivery Business
Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million
Sep 9, 2025 • Yahoo Finance
Boston Sci to Challenge Medtronic in Bioenvelope Market
Sep 9, 2025 • Medical Device and Diagnostic industry
Elutia announces sale of bioenvelopes business to Boston Scientific for $88M
Sep 9, 2025 • thefly.com
Gaithersburg’s Elutia selling key business line to Boston Scientific, sets sights on new products
Sep 9, 2025 • Seattle TechFlash